 |
|
|
| |
High Rates of Medical and Psychiatric Comorbidities in HIV/HCV-Coinfected Patients Treated With Sofosbuvir-Containing Regimens in Registrational Clinical Trials - Harvoni / Epclusa
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Mark Sulkowski,1 Curtis Cooper,2 Jean-Michel Molina,3 Susanna Naggie,4 K.C. Huang,5 Anu Osinusi,5 Luisa M. Stamm,5 Benedetta Massetto,5 John McNally,5 Diana M. Brainard,5 John G. McHutchison,5 David Wyles,6 Jurgen K. Rockstroh,7 Douglas Dieterich8
1Johns Hopkins Hospital, Baltimore, MD; 2University of Ottawa, Ontario, Canada; 3Hopital Saint-Louis, Université Paris-Sorbonne, Paris, France; 4Duke University Medical Center, Durham, NC;
5Gilead Sciences, Inc., Foster City, CA; 6UC San Diego School of Medicine, La Jolla, CA; 7Universität Bonn, Germany; 8Icahn School of Medicine at Mount Sinai, New York, NY
|
| |
|
|
|
|
|
